Intuitive Surgical, Inc. (NASDAQ:ISRG) – Investment analysts at Piper Jaffray Companies boosted their Q4 2018 EPS estimates for Intuitive Surgical in a report issued on Wednesday, January 9th. Piper Jaffray Companies analyst J. Mckim now anticipates that the medical equipment provider will earn $2.53 per share for the quarter, up from their previous estimate of $2.47. Piper Jaffray Companies currently has a “Overweight” rating and a $625.00 target price on the stock. Piper Jaffray Companies also issued estimates for Intuitive Surgical’s Q2 2019 earnings at $2.69 EPS and Q3 2019 earnings at $2.58 EPS.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 18th. The medical equipment provider reported $2.83 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.66 by $0.17. The company had revenue of $920.90 million for the quarter, compared to the consensus estimate of $916.22 million. Intuitive Surgical had a return on equity of 18.79% and a net margin of 22.31%. The company’s revenue for the quarter was up 14.0% on a year-over-year basis. During the same period in the previous year, the business posted $2.77 EPS.

Several other research analysts also recently commented on ISRG. Morgan Stanley lifted their price target on Intuitive Surgical from $575.00 to $600.00 and gave the stock an “overweight” rating in a research report on Thursday, October 11th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $620.00 price target on shares of Intuitive Surgical in a research report on Friday, October 19th. Canaccord Genuity raised Intuitive Surgical from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $550.00 to $610.00 in a report on Friday, October 19th. They noted that the move was a valuation call. Raymond James lifted their price objective on Intuitive Surgical from $620.00 to $630.00 and gave the stock an “outperform” rating in a report on Friday, October 19th. Finally, Royal Bank of Canada reissued a “hold” rating and set a $560.00 price objective on shares of Intuitive Surgical in a report on Friday, October 19th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and seventeen have given a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $563.17.

Shares of NASDAQ ISRG opened at $505.32 on Friday. The company has a market capitalization of $59.05 billion, a price-to-earnings ratio of 70.28, a price-to-earnings-growth ratio of 3.44 and a beta of 1.07. Intuitive Surgical has a 12 month low of $380.00 and a 12 month high of $581.12.

Hedge funds have recently made changes to their positions in the stock. Morgan Stanley boosted its stake in Intuitive Surgical by 119.5% in the 3rd quarter. Morgan Stanley now owns 2,856,195 shares of the medical equipment provider’s stock valued at $1,639,456,000 after buying an additional 1,554,896 shares in the last quarter. CENTRAL TRUST Co boosted its stake in Intuitive Surgical by 26.4% in the third quarter. CENTRAL TRUST Co now owns 460 shares of the medical equipment provider’s stock worth $264,000 after purchasing an additional 96 shares in the last quarter. Crossmark Global Holdings Inc. boosted its stake in Intuitive Surgical by 25.7% in the third quarter. Crossmark Global Holdings Inc. now owns 14,564 shares of the medical equipment provider’s stock worth $8,360,000 after purchasing an additional 2,977 shares in the last quarter. Carillon Tower Advisers Inc. boosted its stake in Intuitive Surgical by 3.7% in the third quarter. Carillon Tower Advisers Inc. now owns 77,953 shares of the medical equipment provider’s stock worth $44,745,000 after purchasing an additional 2,754 shares in the last quarter. Finally, United Capital Management of KS Inc. acquired a new position in Intuitive Surgical in the third quarter worth $205,000. 84.14% of the stock is currently owned by institutional investors and hedge funds.

In related news, VP Jamie Samath sold 864 shares of the business’s stock in a transaction on Tuesday, October 23rd. The stock was sold at an average price of $499.21, for a total value of $431,317.44. Following the sale, the vice president now owns 257 shares of the company’s stock, valued at approximately $128,296.97. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Amal M. Johnson sold 1,000 shares of the business’s stock in a transaction on Tuesday, October 23rd. The shares were sold at an average price of $500.00, for a total value of $500,000.00. Following the completion of the sale, the director now directly owns 9,874 shares in the company, valued at approximately $4,937,000. The disclosure for this sale can be found here. In the last ninety days, insiders sold 72,491 shares of company stock worth $37,767,784. 2.20% of the stock is owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

See Also: What is the Rule of 72?

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.